Head of Investor Relations
BeOne Medicines Ltd. (ONC)Equibles does not estimate personal net worth.
Get an email with a short summary when BeOne Medicines Ltd. publishes a filing, an earnings call transcript or a press release.
Get ONC alertsDaniel Maller is recorded as Head of Investor Relations at BeOne Medicines Ltd. (ONC). Daniel Maller has spoken on 3 earnings calls across 1 company, most recently for BeOne Medicines Ltd. on August 5, 2026. BeOne Medicines Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BeOne Medicines Ltd. includes Mr. John V. Oyler (CEO and Board Member), John V. Oyler (Chairman), Mr. Aaron Rosenberg (CFO) and 7 others.
“Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the investor relations section of our website ir.b1medicine.com. I would like to remind all participants that during this call, we may make forward-looking statements regarding, among other…”
“Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the Investor Relations section of our website, ir.b1medicines.com. I would like to remind all participants that during this call, we may make forward-looking statements regarding, among other…”
“Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the Investor Relations section of our website, ir.beonemedicines.com. I would like to remind all participants that during this call, we may make forward-looking statements regarding, among…”
Biotechnology · Healthcare
Head of Investor Relations
